Showing results (31-40 of 118) with videos related to
Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design of a high affinity peptidomimetic opioid agonist from peptide pharmacophore modelsC Wang, I J McFadyen, J R Traynor, et al.European Journal of Pharmacology|September 24, 1999
Differential binding properties of oripavines at cloned mu- and delta-opioid receptorsK O Lee, H Akil, J H Woods, et al.European Journal of Pharmacology|October 8, 1985
Conversion of dynorphin-(1-9) to [Leu5]enkephalin by the mouse vas deferens in vitroL Miller, M J Rance, J S Shaw, et al.Journal of Embryology and Experimental Morphology|April 1, 1985
Stimulation of division in mouse 3T3 cells by coculture with embryonic chick limb tissueK M Bell, J C McLachlanJournal of Cardiovascular Pharmacology|May 22, 1998
The effect of oxygen and carbon dioxide on tumor cell endothelin-1 productionK M Bell, D J ChaplinJournal of the Royal College of Surgeons of Edinburgh|June 1, 1991
Eye protection for the surgeonK M Bell, D A ClementNIDA Research Monograph|January 1, 1986
Kappa opioid binding sites in rat spinal cordJ R Traynor, M S Wood, J A Carroll, et al.British Journal of Pharmacology|February 18, 2009
Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptorM F Divin, F A Bradbury, F I Carroll, et al.The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeysM C Ko, E R Butelman, J R Traynor, et al.Pageof 12